Literature DB >> 18822302

Functional analysis of HNPCC-related missense mutations in MSH2.

Anne Lützen1, Niels de Wind, Dubravka Georgijevic, Finn Cilius Nielsen, Lene Juel Rasmussen.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is associated with germline mutations in the human DNA mismatch repair (MMR) genes, most frequently MSH2 and MLH1. The majority of HNPCC mutations cause truncations and thus loss of function of the affected polypeptide. However, a significant proportion of MMR mutations found in HNPCC patients are single amino acid substitutions and the functional consequences of many of these mutations in DNA repair are unclear. We have examined the consequences of seven MSH2 missense mutations found in HNPCC families by testing the MSH2 mutant proteins in functional assays as well as by generating equivalent missense mutations in Escherichia coli MutS and analyzing the phenotypes of these mutants. Here we show that two mutant proteins, MSH2-P622L and MSH2-C697F confer multiple biochemical defects, namely in mismatch binding, in vivo interaction with MSH6 and EXO1, and in nuclear localization in the cell. Mutation G674R, located in the ATP-binding region of MSH2, appears to confer resistance to ATP-dependent mismatch release. Mutations D167H and H639R show reduced mismatch binding. Results of in vivo experiments in E. coli with MutS mutants show that one additional mutant, equivalent of MSH2-A834T that do not show any defects in MSH2 assays, is repair deficient. In conclusion, all mutant proteins (except for MSH2-A305T) have defects; either in mismatch binding, ATP-release, mismatch repair activity, subcellular localization or protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822302     DOI: 10.1016/j.mrfmmm.2008.08.015

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  20 in total

Review 1.  Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.

Authors:  Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2015-12-02

2.  Biochemical analysis of the human mismatch repair proteins hMutSα MSH2(G674A)-MSH6 and MSH2-MSH6(T1219D).

Authors:  Hui Geng; Miho Sakato; Vanessa DeRocco; Kazuhiko Yamane; Chunwei Du; Dorothy A Erie; Manju Hingorani; Peggy Hsieh
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

3.  Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.

Authors:  Abhijit Rath; Akriti Mishra; Victoria Duque Ferreira; Chaoran Hu; Gregory Omerza; Kevin Kelly; Andrew Hesse; Honey V Reddi; James P Grady; Christopher D Heinen
Journal:  Hum Mutat       Date:  2019-08-17       Impact factor: 4.878

4.  Bi-directional routing of DNA mismatch repair protein human exonuclease 1 to replication foci and DNA double strand breaks.

Authors:  Sascha E Liberti; Sofie D Andersen; Jing Wang; Alfred May; Simona Miron; Mylene Perderiset; Guido Keijzers; Finn C Nielsen; Jean-Baptiste Charbonnier; Vilhelm A Bohr; Lene J Rasmussen
Journal:  DNA Repair (Amst)       Date:  2010-10-20

5.  Mismatch and base excision repair proficiency in murine embryonic stem cells.

Authors:  Elisia D Tichy; Li Liang; Li Deng; Jay Tischfield; Sandy Schwemberger; George Babcock; Peter J Stambrook
Journal:  DNA Repair (Amst)       Date:  2011-02-18

6.  Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment.

Authors:  Laura Belvederesi; Francesca Bianchi; Cristian Loretelli; Raffaella Bracci; Stefano Cascinu; Riccardo Cellerino
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

7.  Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.

Authors:  Hellen Houlleberghs; Marleen Dekker; Hildo Lantermans; Roos Kleinendorst; Hendrikus Jan Dubbink; Robert M W Hofstra; Senno Verhoef; Hein Te Riele
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

8.  Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.

Authors:  Eugene Izumchenko; John Saydi; Kevin D Brown
Journal:  DNA Repair (Amst)       Date:  2012-10-11

9.  Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo.

Authors:  Adam S Mastrocola; Christopher D Heinen
Journal:  Hum Mutat       Date:  2010-10       Impact factor: 4.878

Review 10.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.